on ABIVAX (EPA:ABVX)
ABIVAX: Share capital and voting rights as of December 31, 2025
ABIVAX, a biotechnology company listed on Euronext Paris under the code FR0012333284, has provided clear information regarding its share capital and voting rights as of December 31, 2025. The company's share capital amounts to €784,441.48, while the total number of shares issued is 78,536,412.
Regarding voting rights, ABIVAX has a total of 82,813,605 theoretical rights. This figure includes all shares, even those without voting rights. Exercisable voting rights also reach this number, indicating that no share is currently without these rights. This data is reported in accordance with AMF regulations, ensuring transparency for investors.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news